Content » Vol 93, Issue 6

Clinical Report

A Case of Rapidly Progressive, Fatal Mycosis Fungoides Presenting as a Haematoma-like Lesion

Tomoyasu Hattori, Akihiko Uchiyama, Osamu Tago, Yayoi Nagai and Osamu Ishikawa

Department of Dermatology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

Mycosis fungoides usually follows an indolent clinical course. We report here a rapidly progressive case of mycosis fungoides with peculiar clinical and histological features, presenting as a haematoma-like mass on the thigh accompanied by multiple reddish brown erythematous lesions on the trunk and extremities. Histopathologically, the erythematous lesions showed epidermotropism of atypical T lymphocytes expressing CD4 and prominent syringotropism without syringometaplasia. The haematoma-like lesion consisted of diffuse and dense infiltrates of medium-to-large-sized pleomorphic lymphocytic cells expressing CD30, suggesting that CD30+ large-cell transformation had occurred. Mycosis fungoides presenting as a haematoma-like lesion is rare and may be a poor prognostic sign. Key words: mycosis fungoides; haematoma; large-cell transformation; syringotropism; CD30.

Accepted Dec 4, 2012; Epub ahead of print Mar 14, 2013

Acta Derm Venereol 2013; 93: XX–XX.

Tomoyasu Hattori, Department of Dermatology, Gunma University Graduate School of Medicine, 3-39-22, Showa-machi, Maebashi, Gunma 371-8511, Japan. E-mail: tohatt@gunma-u.ac.jp

Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma (CTCL), is clinically characterized by a slow progression from patches to plaques, and to tumours in the majority of patients. Histologically, the disease is typified by the proliferation of small cerebriform lymphocytes showing epidermotropism. While MF has a plethora of clinicopathological manifestations (1), MF presenting as a haematoma-like lesion is rare (2). We report here a case of a rapidly progressive, fatal MF with a haematoma-like appearance associated with CD30+ large-cell transformation.

CASE REPORT

A 78-year-old Japanese woman was referred to our hospital with a one-week history of a rapidly enlarging, haematoma-like mass on the back of the right thigh. Physical examination revealed an indurated, focally ulcerated, dome-shaped, purplish skin mass approxi­mately 20 cm in diameter on the posterior aspect of the right thigh (Fig. 1A). Multiple reddish-brown ery­thematous lesions without palpable infiltration were also observed on the trunk and extremities; the time of onset of these lesions was unknown (Fig. 1B). The patient also had right inguinal lymphadenopathy and a subcutaneous left breast mass. Computed tomography revealed an enhanced subcutaneous mass in the right thigh, and multiple enhanced subcutaneous nodules in the extremities, left buttock, right inguinal area and left breast. Based on the above findings, she was diagnosed with cutaneous lymphoma with a traumatic haematoma. However, an incision of the haematoma-like mass revealed neither coagulated clots nor bleeding. Laboratory examination revealed pancytopaenia (white blood cell 3,800/μl, red blood cell 2.95 × 106/μl, haemoglobin 10.3 g/dl, platelet 122 × 103/μl) and elevated values for fibrin/fibrinogen degradation products (FDP) (10.1 μg/ml), D-dimer (5.7 μg/ml), erythrocyte sedimentation rate (16 mm/h), ferritin (1,372.2 ng/ml) and C-reactive protein (1.50 mg/dl). Disseminated intravascular coagulation was considered unlikely. The serum level of soluble interleukin-2 receptor was extremely high (5,658, normal range 135–483 U/ml). Human T-cell lymphotropic virus type I (HTLV-I) serology was negative. Core needle biopsy of the breast revealed a diffuse infiltration of atypical lymphocytes expressing CD3, but not CD20 and CD79α in the mammary gland and surrounding subcutaneous tissue. Biopsy of the lymph node was not performed, and bone marrow biopsy showed no abnormality.

8400.png

Fig. 1. (A) A haematoma-like mass on the posterior aspect of the right thigh. (B) Reddish-brown, non-indurated erythema on the trunk. (C) The non-infiltrated erythema on the left thigh evolved into (D) a violaceous nodule over a period of 2 weeks. A biopsy scar is visible in the centre of the lesion.

Histopathological examination of a biopsy specimen from an erythematous lesion on the left lower leg demonstrated a band-like infiltration of atypical lymphocytes with enlarged, hyperchromatic nuclei and irregular nuclear contours in the upper dermis (Fig. 2A and B). Significant epidermotropism was noted in the epidermis (Fig. 2B). Atypical lymphocytes also infiltrated densely around the eccrine glands and ducts in the reticular dermis; however, neither hyperplastic eccrine glands nor follicular involvement was present (Fig. 2A and C). A phenotypic analysis of the infiltrate revealed a predominance of CD3+ and CD4+ T cells, while CD5, CD8 and CD20 were negative. Monoclonal rearrangement of T-cell receptor Cβ gene was detected. Biopsy specimens taken from the haematoma-like lesion revealed diffuse and dense infiltrates of medium-to-large-sized pleomorphic lymphocytic cells in the epidermis, dermis and subcutaneous fat (Fig. 2D and E) admixed with red blood cells. Infiltrating lymphocytes were positive for CD3, CD30 (Fig. 2F) and MIB-1, partially positive for CD4, and negative for CD5, CD8 and CD20. Based on these findings, the patient was diagnosed with MF (tumour node metastasis blood staging: T3, Nx, M0) with CD30+ large-cell transformation. Multiple erythematous lesions evolved into violaceous plaques or nodules within a short period (Fig. 1C and D). Although local radiation therapy was started to treat the haematoma-like lesion on the thigh, it was ceased after the first session due to the patient’s poor general condition. The patient developed disseminated intravascular coagulation and died approximately 4 weeks after admission.

Fig. 2. (A) Haematoxylin-eosin staining of a biopsy specimen taken from an erythematous lesion on the left lower leg. Microscopically, a band-like lymphocytic infiltration in the upper dermis and a dense infiltration around the eccrine glands and ducts in the reticular dermis were observed on low magnification. (B) An infiltration of atypical lymphocytes with cerebriform nuclei in the epidermis and (C) around the eccrine gland without syringometaplasia was seen on high magnification. (D) Haematoxylin-eosin staining of a biopsy specimen taken from the mass on the right thigh showed diffuse and dense infiltrates with subepidermal blistering. (E) Medium-to-large-sized pleomorphic lymphocytic cells mixed with numerous red blood cells were observed on high magnification. (F) Immunohistochemical staining showed that the large atypical cells were positive for CD30. (Original magnification: A and D ×40; B, C and E ×400; and F ×200).

8431.png

DISCUSSION

MF lesions in the tumour stage are usually dome-shaped, elastic and dark-red in colour. To the best of our knowledge, only one case of CTCL associated with trauma-related haematoma has been reported; the tumour was discovered after the patient presented with a haematoma of the right shin and a biopsy showed a dense infiltration of atypical cells expressing CD45RO but not CD30 in the dermis and subcutaneous tissue with prominent epidermotropism (2). Although the mechanism is unclear, the authors speculated that trauma may influence the growth of a pre-existing neoplasm (2). In our case, a history of preceding trauma was unclear, and erythematous lesions evolved into violaceous plaques or nodules without preceding trauma. Tissue destruction by the heavy infiltrate of atypical cells may have resulted in bleeding within the lesions. For example, certain neoplastic cells may release cytokines or cytotoxic proteins, such as granzyme and T-cell-restricted intracellular antigen, which affect bleeding (3–5).

In the above-mentioned report of MF associated with trauma-related haematoma, the lymphoma had an aggressive clinical course (approximately 6 months from diagnosis to death) and was regarded as d’emblée form of MF (2). The d’emblée form of MF is characterized by rapidly enlarging tumours not preceded by classic patch- and plaque-stage disease. However, d’emblée is now regarded as a clinical descriptive term and not as a subtype in the modern classification of primary cutaneous lymphomas (1, 6, 7). We believe that our case may have been d’emblée form of MF.

A peculiar presentation of MF may be indicative of a more aggressive variant of MF. Some atypical forms of MF, such as folliculotropic MF, bullous MF and granulomatous MF, have been reported to show more aggressive behaviour than classical MF (8–12). In our case, the haematoma-like mass was associated with CD30+ large-cell transformation. Transformation has been defined as the presence of large cells exceeding 25% of the total lymphoid infiltrate or forming microscopic nodules (13). Whereas transformation is associated with a more aggressive biological behaviour and course (13–17), some studies demonstrated that not all patients with transformed MF run an aggressive clinical course (18, 19). Benner et al. (18) recently demonstrated that factors including CD30 negativity, folliculotropic MF and the extent of skin involvement at the time of large-cell transformation were associated with reduced disease-specific survival. Several studies also suggest that CD30 expression in transformed MF might be associated with a better prognosis (14, 15, 17). Therefore, it remains to be determined whether CD30+ large-cell transformation in MF is associated with an aggressive disease course.

“Syringotropic MF”, a rare variant of MF with a prognosis similar to classic MF, is characterized by hyperplastic eccrine glands and eccrine ducts surrounded by a dense infiltrate of atypical lymphocytes with cerebriform nuclei (1, 20–22). Folliculotropic MF is considered to be a closely related condition, as some cases of syringotropic MF demonstrate lymphocytic infiltration involving both eccrine glands and hair follicles (23, 24). On the other hand, lymphoid infiltrates around the eccrine glands without syringometaplasia can be observed in biopsies of conventional MF usually in the tumour stage (22, 25, 26). Previous studies reported that a prominent eccrine infiltration was noted in approximately 30% of biopsy specimens from indisputable cases of MF (25, 26), indicating the syringotropic behaviour of MF. Although syringotropism of atypical T lymphocytes was quite prominent even in the non-infiltrative erythematous lesion, the present case is unlikely to be syringotropic MF because neither syringometaplasia nor follicular involvement was present.

In summary, we described a case of a rapidly progressive MF with peculiar clinical appearance and histological features. The relationship between syringotropism of atypical T lymphocytes and CD30+ large-cell transformation with the haematoma-like appearance is unknown. Doctors should be aware of unusual presentations of MF; we speculate that an unusual haematoma-like appearance of MF may be associated with a poor prognosis.

The authors declare no conflicts of interest.

REFERENCES

1. Kazakov DV, Burg G, Kempf W. Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol 2004; 18: 397–415.

2. Narasimhan P, A
rora A, Hitti I, Glasberg S, Kanzer B. Rapidly progressive fatal cutaneous T cell lymphoma with a trauma-related presentation. Cutis 2000; 66: 195–198.

3. Bowman PH, Hoga
n DJ, Sanusi ID. Mycosis fungoides bullosa: report of a case and review of the literature. J Am Acad Dermatol 2001; 45: 934–939.

4. Vermeer MH, Gee
len FA, Kummer JA, Meijer CJ, Willemze R. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease. Am J Pathol 1999; 154: 1203–1210.

5. Asadullah K, Fr
iedrich M, Haeubetaler A, Sterry W, Docke WD, Volk HD. Granzyme A mRNA expression in mycosis fungoides progression. Blood 1997; 90: 3810–3811.

6. Beljaards RC, M
eijer CJ, Van der Putte SC, Hollema H, Geerts ML, Bezemer PD, et al. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. J Pathol 1994; 172: 53–60.

7. O’Quinn RP, Zi
c JA, Boyd AS. Mycosis fungoides d’emblee: CD30-negative cutaneous large T-cell lymphoma. J Am Acad Dermatol 2000; 43: 861–863.

8. Mantaka P, Hels
ing P, Gjersvik P, Bassarova A, Clausen OP, Delabie J. Clinical and histopathological features of folliculotropic mycosis fungoides: a Norwegian patient series. Acta Derm Venereol 2013; 93: 325–329.

9. Shibata S, Suga
ya M, Minatani Y, Fujita H, Tsunemi Y, Miyagaki T, et al. Folliculotropic mycosis fungoides with severe hepatic failure due to hepatic involvement. Acta Derm Venereol 2009; 89: 423–424.

10. van Doorn R, Sc
heffer E, Willemze R. Follicular mycosis fungoides, a distinct disease entity with or without associated follicular mucinosis: a clinicopathologic and follow-up study of 51 patients. Arch Dermatol 2002; 138: 191–198.

11. McBride SR, Dah
l MG, Slater DN, Sviland L. Vesicular mycosis fungoides. Br J Dermatol 1998; 138: 141–144.

12. Gomez-De La Fue
nte E, Ortiz PL, Vanaclocha F, Rodriguez-Peralto JL, Iglesias L. Aggressive granulomatous mycosis fungoides with clinical pulmonary and thyroid involvement. Br J Dermatol 2000; 142: 1026–1029.

13. Salhany KE, Cou
sar JB, Greer JP, Casey TT, Fields JP, Collins RD. Transformation of cutaneous T cell lymphoma to large cell lymphoma. A clinicopathologic and immunologic study. Am J Pathol 1988; 132: 265–277.

14. Arulogun SO, Pr
ince HM, Ng J, Lade S, Ryan GF, Blewitt O, et al. Long-term outcomes of patients with advanced-stage cutaneous T-cell lymphoma and large cell transformation. Blood 2008; 112: 3082–3087.

15. Barberio E, Tho
mas L, Skowron F, Balme B, Dalle S. Transformed mycosis fungoides: clinicopathological features and outcome. Br J Dermatol 2007; 157: 284–289.

16. Dmitrovsky E, M
atthews MJ, Bunn PA, Schechter GP, Makuch RW, Winkler CF, et al. Cytologic transformation in cutaneous T cell lymphoma: a clinicopathologic entity associated with poor prognosis. J Clin Oncol 1987; 5: 208–215.

17. Vergier B, de M
uret A, Beylot-Barry M, Vaillant L, Ekouevi D, Chene G, et al. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneous Lymphomas. Blood 2000; 95: 2212–2218.

18. Benner MF, Jans
en PM, Vermeer MH, Willemze R. Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases. Blood 2012; 119: 1643–1649.

19. Cerroni L, Rieg
er E, Hodl S, Kerl H. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma. Am J Surg Pathol 1992; 16: 543–552.

20. Yost JM, Do TT,
Kovalszki K, Su L, Anderson TF, Gudjonsson JE. Two cases of syringotropic cutaneous T-cell lymphoma and review of the literature. J Am Acad Dermatol 2009; 61: 133–138.

21. Thein M, Ravat
F, Orchard G, Calonje E, Russell-Jones R. Syringotropic cutaneous T-cell lymphoma: an immuno­phenotypic and genotypic study of five cases. Br J Dermatol 2004; 151: 216–226.

22. Pileri A, Facch
etti F, Rutten A, Zumiani G, Boi S, Fink-Puches R, et al. Syringotropic mycosis fungoides: a rare variant of the disease with peculiar clinicopathologic features. Am J Surg Pathol 2011; 35: 100–109.

23. Jacob R, Scala
M, Fung MA. A case of syringotropic cutaneous T-cell lymphoma treated with local radiotherapy. J Am Acad Dermatol 2009; 60: 152–154.

24. Jacobs MA, Koch
er W, Murphy GF. Combined folliculotropic/syringotropic cutaneous T-cell lymphoma without epidermal involvement: report of 2 cases and pathogenic implications. Hum Pathol 2003; 34: 1216–1220.

25. Rongioletti F,
Smoller B. The histologic value of adnexal (eccrine gland and follicle) infiltration in mycosis fungoides. J Cutan Pathol 2000; 27: 406–409.

26. Hitchcock MG, B
urchette JL, Jr, Olsen EA, Ratech H, Kamino H. Eccrine gland infiltration by mycosis fungoides. Am J Dermatopathol 1996; 18: 447–453.